EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Anterior mitral leaflet modification to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: the PROTECT-LVOT registry

Andrea Ruberti, Fabien Praz, Gerard Martí, Ole De Backer, Ignacio Amat-Santos, Rodrigo Estevez-Loureiro, Philippe Garot, Volker Rudolph, Manel Sabaté, Julio Echarte-Morales, Gerard Roura, Josep Comin und 13 weitere

EuroIntervention · 2026-11 · 22 (22) · 1218-1227

DOI: 10.4244/eij-d-26-00822 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift EuroIntervention, 2026-11. Verfasst von Andrea Ruberti und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Hospital of Bellvitge, Barcelona, Spain. Hauptthemen laut MEDLINE: Transcatheter Mitral Valve Replacement, Ventricular Outflow Obstruction, Left, Mitral Valve, Ventricular Outflow Obstruction. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Left ventricular outflow tract (LVOT) obstruction remains the major limitation of transcatheter mitral valve replacement (TMVR). Anterior mitral leaflet (AML) modification has emerged as a key preventive strategy, yet real-world data remain limited and residual risk is still unknown. AIMS: We sought to evaluate the outcomes of TMVR with concomitant AML modification across valve-in-mitral annular calcification (ViMAC), valve-in-ring (ViR), and valve-in-valve (ViV) substrates. METHODS: We established a multicentre retrospective registry of consecutive patients undergoing TMVR with AML modification between 2017 and 2025. The co-primary in-hospital safety endpoint was a composite of cardiovascular death, stroke/transient ischaemic attack, and major bleeding. RESULTS: A total of 55 patients were included (67% females). The median age was 78 years (interquartile range [IQR] 73-81); the median Society of Thoracic Surgeons Predicted Risk of Mortality was 6.7% (IQR 4.8-9.5). AML modification was performed in 65.5% of cases with the Laceration of the Anterior Mitral leaflet to Prevent Outflow ObstructioN technique and in 34.5% with the Balloon-Assisted Translocation of the Mitral Anterior Leaflet technique. AML modification was successful in 96.4% of cases. Despite successful AML modification, haemodynamically significant LVOT obstruction occurred in 12.7% of cases. The co-primary in-hospital safety endpoint occurred in 20.0% of patients, driven by cardiovascular death in 14.5% of patients. Overall in-hospital mortality was 16.4%. The ViMAC substrate was associated with the numerically highest LVOT obstruction rate (ViMAC 20.7%, ViR 0.0%, ViV 8.3%, odds ratio [OR] 4.72, 95% confidence interval [CI]: 0.89-47.86; p=0.070). The aortomitral angle showed a borderline association with LVOT obstruction (OR 1.22 per degree, 95% CI: 0.99-1.48; p=0.059). CONCLUSIONS: AML modification enables TMVR in high-risk anatomies with high feasibility but does not eliminate LVOT obstruction. ViMAC represents the most challenging substrate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Mitral Valve ReplacementVentricular Outflow Obstruction, LeftMitral ValveVentricular Outflow ObstructionHumansFemaleMaleAgedAged, 80 and overRegistriesRetrospective StudiesTreatment OutcomeHeart Valve Prosthesis

Autor:innen und Institutionen

  • Department of Cardiology, University Hospital of Bellvitge, Barcelona, Spain.
  • Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain.
  • BIO-HEART Group, Institut d'Investigació Biomèdica (IDIBELL), Barcelona, Spain.
  • Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.
  • Department of Cardiology, University Hospital of Vall d'Hebron, Barcelona, Spain.
  • Department of Cardiology, Rigshospitalet, Copenhagen, Denmark.

Zitieren

APA

Ruberti, A., Praz, F., Martí, G., De Backer, O., Amat-Santos, I., Estevez-Loureiro, R., Garot, P., Rudolph, V., Sabaté, M., Echarte-Morales, J., Roura, G., Comin, J., Gercek, M., Muntané-Carol, G., Gómez-Lara, J., Occhipinti, G., Basile, M., Gomez-Hospital, J. A., Angellotti, D., …, & Romaguera, R. (2026). Anterior mitral leaflet modification to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: the PROTECT-LVOT registry. EuroIntervention, 22(22), 1218-1227. https://doi.org/10.4244/eij-d-26-00822

Vancouver

Ruberti A, Praz F, Martí G, De Backer O, Amat-Santos I, Estevez-Loureiro R, et al. Anterior mitral leaflet modification to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: the PROTECT-LVOT registry. EuroIntervention. 2026;22(22):1218-1227. doi:10.4244/eij-d-26-00822

BibTeX
@article{Ruberti2026,
  author = {Ruberti, Andrea and Praz, Fabien and Martí, Gerard and De Backer, Ole and Amat-Santos, Ignacio and Estevez-Loureiro, Rodrigo and Garot, Philippe and Rudolph, Volker and Sabaté, Manel and Echarte-Morales, Julio and Roura, Gerard and Comin, Josep and Gercek, Muhammed and Muntané-Carol, Guillem and Gómez-Lara, Josep and Occhipinti, Giovanni and Basile, Mattia and Gomez-Hospital, Joan A and Angellotti, Domenico and Akodad, Myriam and Regazzoli, Damiano and Martin, Pedro and Moreno, Raúl and Regueiro, Ander and Romaguera, Rafael},
  title = {Anterior mitral leaflet modification to prevent left ventricular outflow tract obstruction during transcatheter mitral valve replacement: the PROTECT-LVOT registry},
  journal = {EuroIntervention},
  year = {2026},
  volume = {22},
  number = {22},
  pages = {1218--1227},
  doi = {10.4244/eij-d-26-00822}
}
Kostenlos starten →